Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

NCT06481241 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Philadelphia Chromosome Negative ALL
Acute Lymphoblastic Leukemia, Adult

Interventions

COMBINATION_PRODUCT: CAR-T cells
DRUG: Venetoclax

Sponsor

Institute of Hematology & Blood Diseases Hospital, China